Head-to-Head asthma strategy trial aims to find best way to prevent dangerous Flare-Ups
NCT ID NCT06596512
Summary
This large study aims to compare two established strategies for managing moderate-to-severe asthma to see which better prevents dangerous flare-ups. It will enroll 4,100 adults who are at risk for asthma exacerbations and currently use inhaled medications. Researchers will directly compare the PARTICS strategy (using a steroid inhaler with each rescue dose) against the MART strategy (using a combination inhaler for both daily maintenance and rescue) over 16 months to see which provides better asthma control and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University
Durham, North Carolina, 27705, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19122, United States
-
University of Wisconsin Madison
Madison, Wisconsin, 53792, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Yale University
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.